Abstract:Purpose: To compare the differences between macromolecular and small molecular contrast agents in interstitial magnetic resonance (MR) lymphography. Materials and Methods: In two groups of rabbits (N = 12 each), 0.5-mL volumes of 0.5 M and 0.1 M gadodiamide, respectively, were injected subcutaneously into the dorsal feet of both hind legs. After a 24-hour interval, 0.5 mL of Gd [DTPA-bis (2-aminoethoxy) ethane] polymeric contrast agent (Gd-poly-DTPA-EOEA) injection (0.1 M) was injected into the same sites in each rabbit. T1-weighted three-dimensional gradient-echo and maximum intensity projection (MIP) images were obtained before and after the administration of each agent. The nodal maximum short-axis diameter (MSAD) and signal-to-noise ratio (SNR) at each time point were measured. Postmortem measurements of nodal MSADs were also performed. The nodal MSAD measurements obtained by MR lymphography were compared with the postmortem measurements. As an additional control experiment, six rabbits received a subcutaneous injection of 0.5 mL of 0.1 M gadodiamide at the same sites as those described above. This procedure was repeated after a 24-hour interval to determine whether the first injected gadodiamide had any effect on the performance of the subsequently injected agent, by comparing the differences in nodal MSADs obtained by MR lymphography after each injection. Results: Gd-poly-DTPA-EOEA showed a significantly longer enhancement plateau compared to gadodiamide. In comparison with postmortem measurements, nodal measurements by MR lymphography with Gd-poly-DTPAEOEA at the peak-enhancement phase revealed no significantly different MSADs (P > 0.05), whereas nodal measurements by MR lymphography with gadodiamide showed significantly smaller MSADs (P < 0.05). A comparison of the nodal MSADs measured in two gadodiamide-enhanced MR examinations after the 24-hour interval showed no significant difference (P > 0.05). Conclusion: Interstitial MR lymphography with polymeric Gd-poly-DTPA-EOEA enhancer enables more sufficient and reliable visualization of lymph nodes compared to small molecular gadodiamide.

Relationship Between High Signal Intensity in the Dentate Nucleus on Unenhanced Tt-weighted MR Images and Gadolinium Contrast Agent Administration

Correlation between high signal intensity in cerebrum nucleus on unenhanced T1-weighted MR images and number of previous gadolinium-based contrast agent administration

Nmr Studies of Gd(Dtpa-Bin) in Human Serum Albumin Solution

Quantitative assessment of gadolinium deposition in dentate nuclei with MR fingerprinting

Gadolinium Deposition in the Liver and Brain in a Rat Model with Liver Fibrosis after Intravenous Administration of Gadoxetate Disodium

Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients

Comprehensive Analysis of the Spatial Distribution of Gadolinium, Iron, Manganese, and Phosphorus in the Brain of Healthy Rats After High-Dose Administrations of Gadodiamide and Gadobutrol

The Effect of Intravenous Administration of Gadolinium Contrast Medium on Diffusion-Weighted MR of Breast

The Development of Dendritic Gd-Dtpa Complexes for Mri Contrast Agents

Effect Of Intravenous Gadolinium-Dtpa On Diffusion-Weighted Imaging For Prostate Lesions And Normal Tissue At 3.0-Tesla Magnetic Resonance Imaging

Increased Liver And Spleen Accumulation Of Tc-99m Methylene Diphosphonate Associated With Intravenous Injection Of Mri Contrast Gadolinium-Diethylenetriaminepentaacetic Acid

Contrast induced myocardial signal reduction: effect of lanthanide chelates on ultra high speed MR images

Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients

The International Society for Magnetic Resonance in Medicine (ISMRM) recommendations on the deposition ofgadolinium in the brain:a brief introduction

Effect of Gd - DTPA on Diffusion Weighted MR Imaging of the Liver, Spleen, and Kidney at 1.5T MR Scanner

Quantification of Gd-DTPA concentration in neuroimaging using T1 3D MP-RAGE sequence at 3.0 T

A Contrast Examination of Proinflammatory Effects on Kidney Function for γ-Fe2O3 NP and Gadolinium Dimeglumine

Evaluation of Intracranial Metastases with China-made Gd-DTPA Contrast Enhancement MRI

The study of correlation between dose of contrast material and enhancement effect in CT scan

Comparison of Gd [DTPA-bis (2-aminoethoxy) ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography: experimental study with rabbits.

The Effect of Gadolinium Chelate Contrast Agent on Diffusion-Weighted Imaging of Pancreatic Ductal Adenocarcinoma